STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2213 by analyst upside · 2026-06-27
SDGR
Schrödinger, Inc.
Healthcare · Market Cap $1B · P/E 0x
ANALYST PRICE TARGET
+23.8%
implied upside to consensus target
Current Price $16.86
Consensus Target $20.88
Bull Target $30.0
Bear Target $13.0
Analysts Covering 8
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
6
Hold
2
Sell
0
52-Week Low $10.95
52-Week High $23.75
YTD Return -6.2%
FUNDAMENTALS
Market Cap $1B
P/E Ratio (TTM) N/A
Forward P/E -10.8x
EPS (TTM) $-1.46
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $255M
Profit Margin -40.6%
52-WEEK RANGE
52-Week Low $10.95
52-Week High $23.75
Current Price $16.86
Bear Target $13.0
Bull Target $30.0
● Now $16.86 ● Target $20.88
TRADING DATA
Avg Volume 1.4M
YTD Return -6.2%
Analyst Count 8
Consensus Buy
Upside to Target +23.8%
Last Updated 2026-06-27

ANALYST SUMMARY

Schrödinger, Inc. (SDGR) is currently trading at $16.86 with a Wall Street consensus price target of $20.88, implying potential upside of 23.8% over the next 12 months. 8 analysts currently cover SDGR, with a consensus rating of Buy - 75% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $30.0, while the most cautious has a target of $13.0.

SDGR operates in the Healthcare sector with a market capitalisation of $1B. The stock is down 6.2% year-to-date and is currently trading near the lower end of its 52-week range of $10.95 – $23.75.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for SDGR, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Morgan Stanley — Reiterated
Equal-Weight → Equal-Weight 2026-05-14 Building track record
Keybanc — Reiterated
Overweight → Overweight 2026-04-08 Building track record
UBS — Reiterated
Neutral → Neutral 2026-03-17 33% win rate (6 calls)
TD Cowen — Reiterated
Buy → Buy 2026-01-08 Building track record
Keybanc — Reiterated
Overweight → Overweight 2026-01-08 Building track record
UBS ● Initiated
Neutral 2026-01-07 33% win rate (6 calls)
B of A Securities ↑ Upgrade
Neutral → Buy 2025-12-15 Building track record
Keybanc — Reiterated
Overweight → Overweight 2025-10-08 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
41
out of 100
Coverage depth
17/30
Consensus clarity
10/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →